Mutations in NF1 and TP53 are found in 20 and 34% of glioblastoma multiforme (GBM) patients, respectively, and those two mutations show significant co-occurrence in ~10% of GBM patients (p-value 0.002) (Supplementary Fig. 9). The gene discussed is NF1; the disease is glioblastoma.